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Familial cold urticaria (FCU) is a rare autosomal dominant inflammatory disorder characterized by intermittent
episodes of rash with fever, arthralgias, conjunctivitis, and leukocytosis. These symptoms develop after generalized
exposure to cold. Some individuals with FCU also develop late-onset reactive renal amyloidosis, which is consistent
with Muckle-Wells syndrome. By analyzing individuals with FCU from five families, we identified linkage to
chromosome 1q44. Two-point linkage analysis revealed a maximum LOD score (Zmax) of 8.13 (recombination
fraction 0) for marker D1S2836; multipoint linkage analysis identified a Zmax of 10.92 in the same region; and
haplotype analysis defined a 10.5-cM region between markers D1S423 and D1S2682. Muckle-Wells syndrome was
recently linked to chromosome 1q44, which suggests that the two disorders may be linked to the same locus.
Familial cold urticaria (FCU) was first described in 1940
by Kile and Rusk; it has also been referred to as familial
polymorphous cold eruption (Martin et al. 1981), cold
hypersensitivity (MIM 120100) (Shepard 1971), cold
pathergy, and cold-specific vasomotor neuropathy (Ur-
bach et al. 1941). Although the exact prevalence of FCU
is unknown, ∼20 different families whose members have
FCU have been reported (Kile and Rusk 1940; Urbach
et al. 1941; Witherspoon et al. 1948; Rodin and Bluefarb
1951; Tindall et al. 1969; Castelain 1971; Shepard 1971;
Derbes and Coleman 1972; Doeglas 1973; Vlagopoulos
et al. 1975; Commerford and Meyers 1977; Wanderer
1979; Martin et al. 1981; Roux et al. 1982; Fordyce
and Coulson 1993; Ormerod et al. 1993; Zip et al. 1993;
Kalogeromitros et al. 1995).
The clinical features of FCU include recurrent attacks
of a nonpruritic, nonurticarial maculopapular exanthem
associated with arthralgias, fever and chills, conjuncti-
vitis, myalgias, headache, fatigue, and swelling of the
extremities (Tindall et al. 1969; Zip et al. 1993). The
onset of symptoms is delayed 30 min to 3 h after ex-
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posure to cold, and symptoms often persist 24–48 h.
The most consistent laboratory finding is marked poly-
morphonuclear leukocytosis, which is found during at-
tacks (Tindall et al. 1969; Doeglas and Bleumink 1974).
The pathological changes in the skin of patients with
FCU during attacks include a primarily polymorpho-
nuclear leukocyte perivascular infiltrate, increased vas-
cularity, and dermal edema, but no vasculitis (Martin et
al. 1981; Tonnesen et al. 1985a; Zip et al. 1993). FCU
manifests as early as birth but no later than early child-
hood, and it persists throughout the person’s life. In
general, people with FCU have normal longevity; how-
ever, patients with FCU from a subset of families studied
(Shepard 1971) also have late-onset renal amyloidosis.
Some of these patients were diagnosed with a variant of
Muckle-Wells syndrome (MWS) (MIM 191900), a con-
dition with variable expression that classically includes
recurrent rash, late-onset progressive nerve deafness, and
late-onset renal amyloidosis (Muckle 1979).
The only significant abnormalities of inflammatory
mediators in FCU are elevations of granulocyte colony-
stimulating factor, interleukin-6 (Urano et al. 1998), and
acute-phase reactants such as C-reactive protein (Ton-
nesen et al. 1985b). Kinins, histamine, and other mast-
cell mediator levels are normal (Tindall et al. 1969; Doe-
glas and Bleumink 1974). Neither cold agglutinins nor
cryoglobulins are present (Vlagopoulos et al. 1975; Kal-
ogeromitros et al. 1995). Despite numerous pathological
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and biochemical investigations, the etiology of FCU re-
mains unknown.
We studied five families that included a total of 69
individuals aged 1–80 years. Families 1, 2, and 3 were
reported elsewhere (Shepard 1971; Vlagopoulos et al.
1975; Wanderer 1979). After informed consent was ob-
tained with a protocol approved by the University of
California at San Diego institutional review board, pa-
tients were evaluated to determine whether they were
affected by FCU. Twenty-six of the 69 family members
studied were affected. One 72-year-old affected individ-
ual from family 2 also had late-onset reactive renal amy-
loidosis, a condition reported in many of her affected
ancestors but not in her monozygotic twin. (We deter-
mined monozygosity by genotyping 120 markers from
three chromosomes.) Families 1 and 2 have extensive
multigenerational pedigrees originating from northern
Europe and dating back to the 18th century. These ped-
igrees are consistent with complete or near-complete
penetrance, and no anticipation is apparent. In families
3, 4, and 5, the first affected family member was iden-
tified only in recent generations, which indicates possible
de novo mutations, incomplete penetrance, or nonpa-
ternity.
Genomic DNA was isolated from the whole blood of
subjects by use of the PureGene DNA isolation kit (Gen-
tra Systems). A whole-genome screening set was devel-
oped by means of sets available from the Cooperative
Human Linkage Center, version 8.0, Marshfield Weber,
version 8a, and Applied Biosystems Inc. (ABI Prism),
version 2. Additional markers were identified with sex-
averaged maps from the Cooperative Human Linkage
Center, Center for Medical Genetics - Marshfield, WI,
USA, ABI Prism, Whitehead Institute for Biomedical Re-
search-MIT Center for Genome Research, Ge´ne´thon,
Genetic Location Database, and Genome Database. Flu-
orescently labeled PCR primers for all markers were syn-
thesized by Gibco BRL (Life Technologies). PCR and
automated genotyping were performed by standard ABI
Prism protocols. Genotype scoring was performed in a
blinded fashion with Fondation Jean Dausset - CEPH
patients 1331 and 1332 as controls. Genotype and ped-
igree data were entered into Cyrillic 2.02 software (Cher-
well Scientific).
Published marker allele frequencies from Fondation
Jean Dausset - CEPH were used because all five FCU
families were white and of northern European descent.
Observed sample allele frequencies were used for two
markers for which the Fondation Jean Dausset - CEPH
allele frequencies were unavailable. Monozygotic twins
from family 2 were treated as one individual with two
marriages for the purpose of linkage analysis, which is
appropriate because penetrance is near 1 (Terwilliger
and Ott 1994). Two-point linkage analysis was per-
formed by the MLINK program of the Linkage 5.2
package (Lathrop et al. 1984) with a dominance trans-
mission model, a penetrance of 0.99, and a genetic fre-
quency of 0.00001. Multipoint linkage analysis was con-
ducted by the following sex-averaged map order:
D1S3462 (18.3 cM)-D1S1594 (2.0 cM)-D1S304 (6.0
cM)-D1S404 (1.0 cM)-D1S1609 (3.3 cM)-D1S423 (4.0
cM)-AFMb005wh9 (4.0 cM)-D1S2836 (2.5 cM)-
D1S2682. This analysis was performed by the GENE-
HUNTER program (Kruglyak et al. 1996) for families
2–5; the analysis could not be used for family 1 because
of its large size. Because of limitations in the LINKAGE
program, available from the Lab of Statistical Genetics,
Rockefeller University, and in related programs (Ter-
williger and Ott 1994), the program SIMPLE (Irwin et
al. 1994) was used to perform a full multipoint linkage
analysis of all nine markers on family 1. Linkage ho-
mogeneity was tested by the HOMOG program (Ott
1991) on both the two-point and multipoint results at
the marker D1S2836.
A whole-genome screen was initiated with the use of
data from family 1 only. After !5% of the screen was
completed, a maximal two-point LOD score (Zmax) of
2.57 (recombination fraction [v] 0.06) was identified for
D1S1609, the most telomeric marker on chromosome
1q from the screening set, prompting follow-up in that
region. Maximal two-point LOD scores for the nearest
markers in the screening set, D1S304 and D1S3462,
were 0.99 (v = 0.12) and 0.00 (v = 0.47), respectively.
We used a combination of databases to choose addi-
tional markers to saturate the region surrounding
D1S1609 with an average resolution of 3 cM (range 1–6
cM). All five families were genotyped for all nine mark-
ers in the region, and LOD score data at incremental
recombination fractions are shown (table 1). Maximal
two-point LOD scores for five markers exceeded 3.00.
The highest two-point LOD scores obtained were 8.13
(v = 0.00) and 7.99 (v = 0.03), for markers D1S2836
and D1S2682, respectively. Linkage analysis at all nine
markers was performed on all families except family 3;
we omitted family 3 because data from its members were
uninformative for linkage, but it was included in the
study for haplotype analysis. Multipoint linkage analysis
of all nine markers for family 1 by SIMPLE resulted in
a maximum multipoint LOD score of 7.19 distal to
D1S423. Multipoint linkage analysis of families 2, 4,
and 5 by GENEHUNTER achieved a LOD of 4.27 be-
tween D1S423 and D1S2682. The combined multipoint
LOD for families 1, 2, 4, and 5 (fig. 1) achieved a Zmax
of 10.92 in the interval between D1S423 and D1S2682.
A one-LOD support interval (Conneally et al. 1985)
spans most of the D1S423–D1S2682 region. No evi-
dence of genetic heterogeneity among the families was
detected at marker D1S2836, with the maximum like-
lihood estimate of the linkage proportion at .a = 1
Haplotype analysis in all five families is shown in fig-
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Figure 1 Multipoint linkage analysis between FCU and nine markers on chromosome 1q43-q44. Genotype information from individuals
from four families was used. Genetic distances between markers are expressed in centimorgans and are calculated on the basis of the sex-
averaged map of the Center for Medical Genetics - Marshfield, WI, USA. Multipoint analysis for family 1 was performed separately, because
of its large size; family 1 data were combined with data from families 2, 4, and 5.
ure 2. Informative recombinant events were seen in the
following family 1 members: affected patient 5 between
D1S423 and D1S2836 (AFMb005wh9 was not infor-
mative); unaffected patient 24 between D1S1609 and
D1S423; affected patient 28 between D1S3462 and
D1S1594; and unaffected patient 29 between D1S1594
and D1S304. The parents of affected patient 8 were not
available for study, but he shared a haplotype consisting
of the five most telomeric markers with his distant rel-
atives. Informative recombinant events were seen in two
family 2 members: affected patient 34 between D1S1609
and AFMb005wh9 (D1S423 was not informative), and
affected patient 41 between D1S2836 and D1S2682. Re-
combination events in family 4 occurred in affected pa-
tient 46 and unaffected patient 50 between D1S3462
and D1S1594. There were no informative recombination
events in families 3 and 5 and no strong evidence for a
shared haplotype between families 1 and 2. Recombi-
national analysis of all family data defined a centromeric
limit at D1S423 and a telomeric limit at D1S2682, a
region of ∼10.5 cM.
This is the first comprehensive report of clear genetic
linkage for FCU in several families. Our data are in
agreement with data presented in abstract form (Jung et
al. 1996) that showed linkage to 1q44 with a Zmax of
7.83 at D1S2836 in two FCU families. Jung et al. defined
a larger region between D1S102 and the telomere. We
delineate a narrower region bound by a centromeric
polymorphic marker (D1S423) that is considerably dis-
tal to D1S102 and a telomeric polymorphic marker
(D1S2682) that is considerably proximal to the telo-
mere.
The linkage of both FCU and MWS to 1q44 and the
presence of patients with both distinct phenotypes pro-
vides additional information regarding the genetic link-
age of the FCU phenotype. Both conditions are char-
acterized by recurrent episodes of rash, arthralgia,
myalgia, fever, conjunctivitis, and leukocytosis and by
elevated serum interleukin-6 levels (Gerbig et al. 1998;
Urano et al. 1998). However, patients with FCU develop
these symptoms only after exposure to cold, and patients
with MWS develop symptoms without such exposure.
Patients with MWS variably express late-onset nerve
deafness and renal amyloidosis (Muckle 1979; Gerbig
et al. 1998), but these phenotypes are not seen in families
with FCU alone. Therefore, there is a distinct constel-
lation of symptoms common to both syndromes, but the
correlation to cold exposure is unique to FCU and the
nerve deafness is unique to MWS. MWS has been linked
to chromosome 1q44 in three families with a Zmax of
4.66 at D1S2836 and a region defined by recombina-
tional analysis of 13.9 cM between D1S2811 and
D1S2682 (Cuisset et al. 1999).
The phenotype similarity and genetic linkage to the
same region could be explained in several ways. Micro-
deletions of different sizes in the region of two close but
Figure 2 Haplotypes for nine markers from 1q43-q44 for five families with FCU. Genetically uninformative cases are not included.
Marker order is shown to the left of each generation. Disease-linked haplotypes are indicated by being boxed. Key recombination events are
observed between D1S423 and D1S2836 in patient 5 (family 1), between D1S1609 and D1S423 in patient 34 (family 2), and between D1S2836
and D1S2682 in patient 41 (family 2).
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Table 1
Cumulative Two-Point Linkage Analysis for Individuals with FCU from Four Families
LOD SCORE AT v =
MARKER .00 .01 .05 .1 .2 .3 .4 Zmax v
D1S3462 220.43 26.54 23.66 22.28 2.97 2.36 2.06 .00 .48
D1S1594 1.66 1.63 1.52 1.37 1.04 .65 .24 1.66 .00
D1S304 2.46 2.69 2.89 2.79 2.24 1.49 .66 2.89 .05
D1S404 210.16 .34 2.44 2.95 2.69 1.77 .72 2.98 .12
D1S1609 22.84 3.45 4.15 4.10 3.39 2.37 1.20 4.18 .07
D1S423 4.01 3.94 3.63 3.24 2.44 1.60 .75 4.01 .00
AFMb005wh9 5.37 5.27 4.83 4.27 3.09 1.85 .70 5.37 .00
D1S2836 8.13 7.99 7.42 6.69 5.14 3.44 1.62 8.13 .00
D1S2682 3.70 7.86 7.85 7.23 5.57 3.62 1.57 7.99 .03
separate genes could result in individuals with one or
both phenotypes. The phenotypic pattern observed
could also be explained by two genes that code for prod-
ucts in the same pathway or by variable mutations in a
common promoter for both genes. It is also possible that
FCU and MWS represent different mutations within a
single gene or variable expression of the same gene be-
cause of genetic or environmental factors.
Recently, the molecular and genetic bases of several
autoinflammatory or periodic fever disorders have been
elucidated, including familial Mediterranean fever, fa-
milial Hibernian fever, and familial periodic fever (Gra-
teau et al. 1999). As with FCU, these disorders present
as self-limited episodes of fever with synovial and cu-
taneous inflammation. However, unlike FCU, serosal in-
flammation such as sterile peritonitis and pleurisy are
common features of these conditions. As with MWS, the
primary morbidity in these disorders is from renal amy-
loidosis. FCU and MWS may be seen as members of this
group of disorders. As further studies are conducted, the
molecular basis of these inflammatory disorders may
shed light on the mechanisms involved in FCU and
MWS.
Sensitivity to cold is the one unique feature of FCU
and is perhaps the most intriguing mechanism to un-
ravel. The identification of the gene underlying FCU will
not only be of importance in understanding the patho-
physiology and possible treatment of FCU, but may also
provide insight into mechanisms of other chronic in-
flammatory processes and the inflammatory responses
induced by physical stimuli such as cold.
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